- Comparable short-term efficacy: Sliding cupping and NBUVB resulted in similar improvements in PASI and other clinical outcomes, with no significant between-group differences.
- Meaningful clinical response: Around 70%–80% of patients in both groups achieved at least a 30% improvement in PASI scores by week 8.
- Symptom and QoL improvements: Both treatments reduced itch severity and improved dermatology-specific quality of life (DLQI), though patient-reported QoL did not significantly change.
- Favorable safety profile: Adverse events were mild, infrequent, and similar between groups, with no serious adverse events observed.
- Limitations temper conclusions: Small sample size, short follow-up, lack of full blinding, and operator-dependent intervention limit generalizability and prevent conclusions about equivalence or long-term efficacy.
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
